Medinice S.A.
ICE.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Gross Profit | -PLN 0 | -PLN 0 | -PLN 0 | PLN 1 |
| % Margin | – | – | – | 5,652.6% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| SG&A Expenses | PLN 0 | PLN 0 | PLN 1 | PLN 0 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | PLN 1 | PLN 2 | PLN 0 | -PLN 41 |
| Operating Expenses | PLN 1 | PLN 2 | PLN 1 | -PLN 41 |
| Operating Income | -PLN 1 | -PLN 2 | -PLN 1 | PLN 41 |
| % Margin | – | – | – | 214,852.6% |
| Other Income/Exp. Net | -PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Pre-Tax Income | -PLN 1 | -PLN 2 | -PLN 1 | PLN 41 |
| Tax Expense | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Net Income | -PLN 1 | -PLN 2 | -PLN 1 | PLN 41 |
| % Margin | – | – | – | 215,205.3% |
| EPS | -0.11 | -0.2 | -0.16 | 6.14 |
| % Growth | 45% | -25% | -102.6% | – |
| EPS Diluted | -0.11 | -0.2 | -0.16 | 6.14 |
| Weighted Avg Shares Out | 8 | 8 | 7 | 7 |
| Weighted Avg Shares Out Dil | 8 | 8 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| EBITDA | -PLN 1 | -PLN 1 | -PLN 1 | PLN 41 |
| % Margin | – | – | – | 215,542.1% |